Production (Stage)
Compugen Ltd.
CGEN
$1.65
$0.010.61%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Revenue | -- | 42.72M | 36.02M | 33.46M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | 42.72M | 36.02M | 33.46M | |
| Cost of Revenue | -- | 5.66M | 4.11M | 2.00M | |
| Gross Profit | -- | 37.06M | 31.91M | 31.46M | |
| SG&A Expenses | -- | 9.75M | 9.83M | 9.98M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | 47.27M | 47.37M | 46.45M | |
| Operating Income | -- | -4.55M | -11.35M | -12.99M | |
| Income Before Tax | -- | -509.00K | -7.72M | -9.78M | |
| Income Tax Expenses | -- | 9.02M | 8.96M | 8.97M | |
| Earnings from Continuing Operations | -- | -9.53 | -16.68 | -18.75 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -9.53M | -16.68M | -18.75M | |
| EBIT | -- | -4.55M | -11.35M | -12.99M | |
| EBITDA | -- | -4.07M | -10.87M | -12.51M | |
| EPS Basic | -- | -0.11 | -0.19 | -0.22 | |
| Normalized Basic EPS | -- | 0.12 | 0.06 | 0.06 | |
| EPS Diluted | -- | -0.11 | -0.19 | -0.22 | |
| Normalized Diluted EPS | -- | 0.12 | 0.06 | 0.06 | |
| Average Basic Shares Outstanding | -- | 355.76M | 353.41M | 350.53M | |
| Average Diluted Shares Outstanding | -- | 355.76M | 353.41M | 350.53M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |